Home/Filings/4/0001562180-21-005226
4//SEC Filing

Greene Barry E 4

Accession 0001562180-21-005226

CIK 0001597553other

Filed

Aug 8, 8:00 PM ET

Accepted

Aug 9, 9:07 AM ET

Size

6.9 KB

Accession

0001562180-21-005226

Insider Transaction Report

Form 4
Period: 2021-08-05
Greene Barry E
DirectorPresident and CEO
Transactions
  • Purchase

    Common Stock

    2021-08-05$43.15/sh+23,640$1,020,05432,440 total
Footnotes (1)
  • [F1]This transaction was executed in multiple trades at prices ranging from $42.66 USD to $43.46 USD. The price reported above reflects the weighted average purchase price. The issuer hereby undertakes to provide, upon request, to the SEC staff or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Issuer

Sage Therapeutics, Inc.

CIK 0001597553

Entity typeother

Related Parties

1
  • filerCIK 0001291963

Filing Metadata

Form type
4
Filed
Aug 8, 8:00 PM ET
Accepted
Aug 9, 9:07 AM ET
Size
6.9 KB